Equinox Group is a specialized consulting firm that assesses the clinical and commercial merit of drugs in development. We offer innovative analysis, cutting-edge forecasting techniques, and substantial experience to help clients solve problems at all phases of R&D: • Measure the value of new drugs • Select diseases for drug discovery • Assess technical feasibility • Set therapeutic area strategy • Analyze the R&D portfolio